Weber Michaela, Weber Friedemann
Institute for Virology, Philipps-University Marburg, D-35043 Marburg, Germany.
Institute for Virology, Philipps-University Marburg, D-35043 Marburg, Germany.
Cytokine Growth Factor Rev. 2014 Oct;25(5):621-8. doi: 10.1016/j.cytogfr.2014.05.004. Epub 2014 May 20.
Negative strand RNA viruses with a nonsegmented genome (ns-NSVs) or a segmented genome (s-NSVs) are an important source of human and animal diseases. Survival of the host from those infections is critically dependent on rapidly reacting innate immune responses. Two cytoplasmic RNA helicases, RIG-I and MDA5 (collectively termed RIG-I-like receptors, RLRs), are essential for recognizing virus-specific RNA structures to initiate a signalling cascade, resulting in the production of the antiviral type I interferons. Here, we will review the current knowledge and views on RLR agonists, RLR signalling, and the wide variety of countermeasures ns-NSVs and s-NSVs have evolved. Specific aspects include the consequences of genome segmentation for RLR activation and a discussion on the physiological ligands of RLRs.
具有非节段基因组(ns-NSV)或节段基因组(s-NSV)的负链RNA病毒是人类和动物疾病的重要来源。宿主从这些感染中存活下来严重依赖于快速反应的先天免疫反应。两种细胞质RNA解旋酶,视黄酸诱导基因I(RIG-I)和黑色素瘤分化相关基因5(MDA5)(统称为RIG-I样受体,RLR),对于识别病毒特异性RNA结构以启动信号级联反应至关重要,从而导致抗病毒I型干扰素的产生。在这里,我们将综述关于RLR激动剂、RLR信号传导以及ns-NSV和s-NSV所进化出的各种对策的当前知识和观点。具体方面包括基因组节段化对RLR激活的影响以及对RLR生理配体的讨论。